Literature DB >> 2315784

Thallium-201 scintigraphy in the diagnosis and management of myocardial sarcoidosis.

C L Fields1, M A Ossorio, T M Roy, D M Denny, D W Varga.   

Abstract

We have described three patients with clinical evidence of myocardial sarcoidosis to illustrate the utility of thallium-201 scintigraphy in demonstrating the myocardial lesions. Both the symptomatic and asymptomatic individuals studied showed the characteristic "reverse redistribution" phenomenon. No abnormalities were seen during the exercise phase of the thallium study, but myocardial defects were detected in each patient when repeat studies were obtained at rest six hours later. Steroid therapy resolved the defects in each case. We propose thallium-201 scintigraphy of the heart as a safe and useful tool for documenting myocardial involvement in sarcoidosis and following the effects of therapy.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2315784     DOI: 10.1097/00007611-199003000-00022

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  9 in total

1.  Rest-redistribution thallium-201 myocardial scintigraphic study in cardiac amyloidosis.

Authors:  K Kodama; M Hamada; T Kuwahara; M Nakamura; Y Shigematsu; K Hiwada; T Iwata; Y Hoshii; T Ishihara
Journal:  Int J Card Imaging       Date:  1999-10

Review 2.  Cardiac sarcoidosis.

Authors:  Abdul R Doughan; Byron R Williams
Journal:  Heart       Date:  2006-02       Impact factor: 5.994

3.  Reverse redistribution: is it clinically relevant or a washout?

Authors:  J A Arrighi; R Soufer
Journal:  J Nucl Cardiol       Date:  1998 Mar-Apr       Impact factor: 5.952

Review 4.  Advanced imaging of cardiac sarcoidosis.

Authors:  Chadi Ayoub; Elena Pena; Hiroshi Ohira; Alexander Dick; Eugene Leung; Pablo B Nery; David Birnie; Rob S B Beanlands
Journal:  Curr Cardiol Rep       Date:  2015       Impact factor: 2.931

Review 5.  Cardiac sarcoidosis: diagnostic, prognostic, and therapeutic considerations.

Authors:  M Sekiguchi; Y Yazaki; M Isobe; M Hiroe
Journal:  Cardiovasc Drugs Ther       Date:  1996-11       Impact factor: 3.727

Review 6.  Idiopathic giant cell myocarditis and cardiac sarcoidosis.

Authors:  Lori A Blauwet; Leslie T Cooper
Journal:  Heart Fail Rev       Date:  2013-11       Impact factor: 4.214

7.  Clinical value of a high-fat and low-carbohydrate diet before FDG-PET/CT for evaluation of patients with suspected cardiac sarcoidosis.

Authors:  Michael Soussan; Pierre-Yves Brillet; Hilario Nunes; Gabriel Pop; Matthieu-John Ouvrier; Nicolas Naggara; Dominique Valeyre; Pierre Weinmann
Journal:  J Nucl Cardiol       Date:  2012-11-28       Impact factor: 5.952

8.  Cardiac sarcoidosis: a comprehensive review.

Authors:  Vishal Sekhri; Shireen Sanal; Lawrence J Delorenzo; Wilbert S Aronow; George P Maguire
Journal:  Arch Med Sci       Date:  2011-09-02       Impact factor: 3.318

Review 9.  Sarcoidosis: Pitfalls and Challenging Mimickers.

Authors:  Naureen Narula; Michael Iannuzzi
Journal:  Front Med (Lausanne)       Date:  2021-01-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.